- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Peter Leininger (Pete)
News 3 results
In the News · Source: FDAnews
October 31, 2022
Mark Brown, Pete Leininger and Beverly Lorell explain how the COVID-19 pandemic has upended the conduct of clinical trials in a number of ways
In the News · Source: Bloomberg Law
Press Release
June 5, 2017
FDA Associate Chief Counsel for Enforcement Joins King & Spalding
Events 4 results
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Conference
June 21, 2018
West Coast Pharmaceutical & Medical Device University
Insights 3 results
Article · Source: Law360
April 20, 2023
Ex-Blue Bell CEO Plea Highlights Enforcement Risk In Recalls
Article · Source: WCG CenterWatch
November 1, 2022
Clinical Data Integrity: FDA and DOJ Enforcement Priorities
Client Alert
May 5, 2021
Genus Medical Technologies LLC v. FDA: D.C. Circuit Holds FDA Cannot Regulate Devices as Drugs